Market Overview

Janney Capital Initiates Coverage on PDL BioPharma, Inc. at Neutral, Announces $7.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for PDLI

DateFirmActionFromTo
May 2013Piper JaffrayInitiates Coverage onNeutral
Mar 2013JP MorganMaintainsNeutral
Jan 2013Credit SuisseDowngradesNeutralUnderperform

View More Analyst Ratings for PDLI
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (PDLI)

Around the Web, We're Loving...

Get Benzinga's Newsletters